文献速递自身炎症与 IgG4 相关病

187例未定义自身炎症性疾病的临床特征与遗传分析

Clinical characteristics and genetic analyses of 187 patients with undefined autoinflammatory diseases.
PubMed 文献 · Ann Rheum Dis · 2019-07-05

本研究基于Eurofever注册库,描述了187例未定义系统性自身炎症性疾病(SAID)患者的临床特征、治疗反应和遗传发现。患者以反复发作病程为主,中位发病年龄4.3岁,常见关节痛、肌痛、腹痛、疲劳和黏膜皮肤表现;15例发现自身炎症基因变异,基因变异者亲属受累更常见(p=0.005)。心包炎和智力障碍患者构成不同亚群。

要点

  • 未定义SAID患者多为反复发作病程,中位发病年龄4.3岁,年发作中位12次、持续4天。
  • 常见症状包括关节痛、肌痛、腹痛、疲劳、不适和黏膜皮肤表现。
  • 15例发现自身炎症基因变异,其亲属受累比例高于无变异者(p=0.005)。

核心结论

  • 未定义SAID患者具有异质性临床表现,心包炎和智力障碍患者可能构成不同亚群。

研究设计与样本

  • 从Eurofever国际网络注册库提取未定义SAID患者的临床和遗传数据,共纳入187例。

主要发现

  • 7例为慢性病程,180例为反复发作病程,中位发病年龄4.3岁,年发作中位12次、持续4天。
  • 常见症状为关节痛(n=113)、肌痛(n=86)、腹痛(n=89)、疲劳(n=111)、不适(n=104)和黏膜皮肤表现(n=128)。
  • 24例有亲属受累,15例发现自身炎症基因变异,基因变异者亲属受累更常见(p=0.005)。
  • 心包炎患者(n=11)发病年龄较大(33.8岁)且年发作次数较少(3.0次/年)。
  • 智力障碍患者(n=8)发病年龄较小(2.2岁)且亲属受累常见(28.6%)。

临床怎么用

  • 对未定义SAID患者应详细采集家族史和基因检测,尤其亲属受累者。
  • 心包炎和智力障碍患者可视为不同临床亚群,需个体化评估。
  • 多数患者对NSAIDs、糖皮质激素、秋水仙碱和阿那白滞素反应良好,但单用NSAIDs完全缓解罕见。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To describe the clinical characteristics, treatment response and genetic findings in a large cohort of patients with undefined systemic autoinflammatory diseases (SAIDs). METHODS: Clinical and genetic data from patients with undefined SAIDs were extracted from the Eurofever registry, an international web-based registry that retrospectively collects clinical information on patients with autoinflammatory diseases. RESULTS: This study included 187 patients. Seven patients had a chronic disease course, 180 patients had a recurrent disease course. The median age at disease onset was 4.3 years. Patients had a median of 12 episodes per year, with a median duration of 4 days. Most commonly reported symptoms were arthralgia (n=113), myalgia (n=86), abdominal pain (n=89), fatigue (n=111), malaise (n=104) and mucocutaneous manifestations (n=128). In 24 patients, relatives were affected as well. In 15 patients, genetic variants were found in autoinflammatory genes. Patients with genetic variants more often had affected relatives compared with patients without genetic variants (p=0.005). Most patients responded well to non-steroidal anti-inflammatory drugs (NSAIDs), corticosteroids, colchicine and anakinra. Complete remission was rarely achieved with NSAIDs alone. Notable patterns were found in patients with distinctive symptoms. Patients with pericarditis (n=11) were older at disease onset (33.8 years) and had fewer episodes per year (3.0/year) compared with other patients. Patients with an intellectual impairment (n=8) were younger at disease onset (2.2 years) and often had relatives affected (28.6%). CONCLUSION: This study describes the clinical characteristics of a large cohort of patients with undefined SAIDs. Among these, patients with pericarditis and intellectual impairment appear to comprise distinct subsets.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Ter Haar NM, Eijkelboom C, Cantarini L, et al. Clinical characteristics and genetic analyses of 187 patients with undefined autoinflammatory diseases. Ann Rheum Dis. 2019. PMID: 31278138. doi:10.1136/annrheumdis-2018-214472

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。